Wordt geladen...
Anti-Drug Antibodies: Emerging Approaches to Predict, Reduce or Reverse Biotherapeutic Immunogenicity
The development of anti-drug antibodies (ADAs) following administration of biotherapeutics to patients is a vexing problem that is attracting increasing attention from pharmaceutical and biotechnology companies. This serious clinical problem is also spawning creative research into novel approaches t...
Bewaard in:
| Gepubliceerd in: | Antibodies (Basel) |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6698869/ https://ncbi.nlm.nih.gov/pubmed/31544871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antib7020019 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|